Avita Medical (ASX:AVH) reported Friday that its first quarter loss narrowed to $0.53 per diluted share from $0.73 per diluted share a year earlier.
Analysts polled by Visible Alpha expected a loss of $0.45 per diluted share.
Total revenue for the three months ended March 31 was $18.5 million, compared with $11.1 million a year earlier. Analysts surveyed by Visible Alpha expected $20.1 million.
The company reaffirmed its full-year 2025 guidance, anticipating commercial revenue of between $100 million and $106 million, indicating a 55% to 65% growth from a year earlier.
Shares fell nearly 20% in morning trade Friday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。